Background-We hypothesized that the incidence of previous percutaneous coronary intervention (PCI) is increasing and that prior PCI influences patient morbidity and mortality after coronary artery bypass grafting (CABG).
with complex calcified vessels that are difficult to stent. The net result is that patients are often referred for CABG who frequently have undergone previous PCI.
The impact of prior PCI in patients undergoing CABG remains unclear. Previous studies have documented increased mortality in patients undergoing CABG with prior PCI; however, a recent, international, multicenter study suggested no such differences. Moreover, no study has evaluated the effect of previous PCI on major morbidities after CABG. We sought to determine whether the incidence of prior PCI has increased in patients undergoing CABG with the advent of DES. Furthermore, we hypothesized that patients with previous PCI undergoing CABG have worse morbidity and mortality than those patients undergoing CABG without previous PCI.
METHODS

Data collection
The Virginia Cardiac Surgery Quality Initiative (VCSQI) is a voluntary consortium of 16 different cardiac surgical centers and hospitals within the Commonwealth of Virginia that collectively captures approximately 99% of Virginia's cardiac operative procedures. Data analyses were exempt from the University of Virginia Institutional Review Board because the VCSQI database has no patient identifiers. In addition, participating institutions were exempt from Health Insurance Portability and Accountability Act consideration by the use of the Small Business Agreement for Business Associates agreements between each hospital and participating surgeons.
Patients
A total of 34,316 patients who underwent isolated CABG operations from 2001 to 2008 were reviewed. Isolated CABG operations were defined as those not accompanied by any other cardiac procedures. The exclusion criteria used for the study were: (1) concomitant PCI and CABG surgeries during same admission, (2) unsuccessful PCI necessitating urgent or emergent CABG, and (3) patients requiring other cardiac procedures such as valve or aneurysm repair, concurrently during CABG. Patients were stratified into 2 groups of prior PCI (n = 4346; 12.7%) and no PCI (n = 29,970).
The VCSQI contained detailed information on patient demographics, preoperative risk factors, operative notes, hospital duration of stay, and morbidity and mortality outcomes. The outcomes of interest were operative mortality and the composite incidence of major complications, which was defined as occurrence of ≥1 or more of the following within 30 days of surgery: Perioperative myocardial infarction (MI; 0-24 hours postoperatively), stroke (permanent; not resolved within 24 hours), prolonged ventilation (>24 hours), pneumonia (diagnosed by positive cultures of sputum, transtracheal fluid, bronchial washings, and/or clinical findings consistent with the diagnosis of pneumonia including chest x-ray diagnostic of pulmonary infiltrates), acute renal failure (1 or both of the following: Serum creatinine 3× times baseline or ≥4.0 and new requirement for postoperative dialysis) and new-onset hemodialysis (may include peritoneal or hemodialysis). Established STS definitions for all preoperative and operative variables as well as postoperative outcomes, were used. 2 Operative mortality included patient deaths that occurred before hospital discharge or within 30 days of surgery.
Statistical analysis
Appropriate tests were performed to assess the null hypothesis that outcomes after CABG were equivalent despite performance of prior PCI. Statistical significance was determined using an alpha of <.05. Descriptive statistics were utilized to analyze observed differences in patient characteristics, operative details, and postoperative outcomes as they related to the prior performance of PCI. Accordingly, univariate categorical comparisons were performed using either Pearson's chi-square or the Fisher exact tests. All categorical variables are presented as with-in group percentages. Continuous variables are reported as either mean values ± standard deviation for variables with normal distribution within the dataset or median (interquartile range) for all non-normally distributed data. Continuous variables were compared using the Student's t test or the Mann-Whitney U test for non-parametric data. All pairwise group comparisons represent the comparison of independent samples. All calculated test statistics were used to derive reported 2-tailed P values.
Multivariable logistic regression analysis was utilized to estimate the risk-adjusted effects of performance of prior PCI on the odds of operative mortality and major complications. Two separate logistic regression models were performed. The models utilized in this study proved to be adequate performers for the outcomes of mortality and composite incidence of major complications. In each model, potential confounders for patient mortality and major complications were included as covariates (Society of Thoracic Surgeons Predicted Risk of Mortality-STS PROM, operative year, number of arterial and venous bypass grafts, cardiopulmonary bypass time, and performance of prior PCI). The selection of these covariates was determined a priori, and all covariates were included in each model. Factors with strong colinearity were accounted for and competing variables were eliminated from the model. In each model, all variables entered were retained. The estimated measures of association for potential confounder is reported as an adjusted odds ratios (OR) with a 95% confidence interval (CI), and the relative contribution of each covariate to the model was assessed using the Wald chi-square statistic. The performance of each model was assessed by the area under the receiver operator characteristics curve and the Hosmer Lemeshow goodness-of-fit test. 
RESULTS
Incidence of PCI has increased over time
Preoperative and intraoperative risk factors
Patient demographics and preoperative risk factors are presented in Table I . Patients with prior PCI were comparatively younger (P < .001) and more commonly presented with preoperative diabetes, dyslipidemia, hypertension, and previous MI (P < .001). In addition, this patient group had a greater incidence of previous CABG. However, prior PCI patients were less likely to have heart failure (P <.001), a family history of CAD (P <.001), or a smoking history (P = .039). Likely because of the presence of a coronary stent in the prior PCI group, their preoperative use of clopidogrel was substantially higher than their counterparts (P <.001). Increased rates of preoperative ventricular arrhythmias were also noted in the prior PCI group (P < .001); however, preoperative atrial arrhythmia rates were not different. Prevalence of preoperative chronic lung diseases in various severities (P < . 0001) was greater in prior PCI group. Despite these differences, the STS preoperative predicted risk of mortality between the groups was similar (P = .1).
Intraoperative outcomes are presented in Table II . Emergent operations were more common in the prior PCI group while the no PCI group had a greater number of elective surgeries (P <.001). The use of a single internal mammary artery as well as double internal mammary artery was incrementally lower in the prior PCI group compared with the no PCI group (P < .001). Notably, aortic cross-clamping and total cardiopulmonary bypass times were not different between the groups undergoing CABG despite the performance of prior PCI.
Morbidity, not mortality, was higher with prior PCI
The postoperative outcomes are presented in Table III . Operative mortality was low and similar between groups (2.3% vs 1.9%; P = .13). There were no differences between postoperative atrial arrhythmia rates between the 2 groups. However, patients with prior PCI had composite incidence ≥1 major complications such as perioperative MI, stroke, prolonged ventilation, pneumonia, acute renal failure, and new-onset hemodialysis (15% vs 12%; P < .001; Fig 2) . Moreover, patients with prior PCI had higher rates of reoperation for bleeding likely owing to higher preoperative Clopidogrel use (P < .001). Finally, prior PCI patients had longer hospital lengths of stay (P ≤ .001) and higher readmission rates within 30 days of procedure (P = .01).
Prior PCI-independent risk factor for major complications
After accounting for patient and operation related risk factors, multivariable logistic regression demonstrated that prior PCI was not significantly associated with operative mortality after isolated CABG (OR, 1.17; 95% CI, 0.91-1.51; P = .23). However, it was an independent predictor of major complications (OR, 1.15; 95% CI, 1.04-1.28; P = .01). Each model proved to be an adequate performer with area under the receiver operator characteristics of 0.78 and 0.71 for the outcomes of mortality and major complications, respectively. The models were well calibrated with Hosmer-Lemeshow P values of <.05 .
DISCUSSION
Using a multicenter, retrospective analysis from 16 different statewide cardiac centers, we demonstrate that the incidence of PCI in patients undergoing CABG has risen since the introduction of DES in 2004. The objective of the study was to investigate the independent effect of prior PCI in patients undergoing CABG. Although there was no relationship between prior PCI and mortality after CABG, we determined that the risk-adjusted inhospital major morbidity is worse in patients with prior PCI.
For multiple reasons, the utilization of PCI in the United States has increased. PCI has become the primary treatment for many patients with CAD. In addition, early detection of CAD in patients has further lead to greater use of PCI. Even though several randomized trials and large studies [3] [4] [5] [6] have clearly established CABG as the preferred modality over PCI for coronary revascularization in multivessel disease, patients often still undergo PCI as first line therapy owing to referral patterns and less invasive nature of this treatment. Particular preference of PCI use also stems from the common theory that if it fails, CABG could still be used to establish revascularization. The recent criticism of long term DES outcomes being less efficacious also draws into question the "stent first" approach used to treat CAD. 7, 8 In select practices, even higher risk patient populations with multivessel diseases and diabetes are referred for PCI as initial treatment. 9, 10 Of patients with complex coronary lesions and multivessel involvement treated with PCI, 20-40% have evidence of restenosis and a need for subsequent re-vascularization. 11 As a result, the incidence of previous PCI has increased as much as 25% in patients undergoing CABG as seen in the present study. Reports regarding worse outcomes in prior PCI patients with repeat PCI have been documented. 12 As such, studies indicating increased incidence of major adverse cardiac events in patients with prior PCI undergoing noncardiac surgical scenarios [13] [14] [15] and worse early mortality outcomes when prior angioplasty was followed up by a subsequent CABG 16 come as no surprise.
Previous studies have not clearly outlined the effect of prior PCI on outcomes in patients undergoing CABG. Studies of smaller magnitude have produced conflicting results. Historical studies have shown worse mortality outcomes in patients with prior PCI; however, these studies were in the early experience with PCI. [17] [18] [19] In contrast, a recent Australasian multicenter retrospective study conducted in 13,184 patients (11.1% prior PCI) showed no association between prior PCI and short and midterm mortality after CABG, 20 a finding that is consistent with our results. However, regarding morbidity, this international study focused only on major adverse cardiac events, composed of the composite endpoint of in-hospital death, MI, or stroke, and did not investigate other relevant complications, including pulmonary and renal complications, which can contribute significantly to the morbidity of the patient. That study did demonstrate postoperative renal failure was significantly higher in prior PCI patients, similar to our study. Specifically, we noted patients with prior PCI had a 4% incidence in postoperative acute renal failure, nearly 25% higher than those patients without previous percutaneous intervention.
The present study has the largest cohort size to date, thus depicting a wider distribution of patient population, and was unique in that it evaluated an additional endpoint of major complications, including perioperative MI, stroke, prolonged ventilation, pneumonia, acute renal failure, and new-onset hemodialysis. Each of these major complications was selected because they have been shown to have major impact in patient morbidity. For example, postoperative pulmonary dysfunction after CABG surgery is associated with a longer duration of mechanical ventilation, difficulty weaning the patient, and prolonged hospitalization, and may be associated with higher mortality. [21] [22] [23] Acute renal failure has clearly been linked with postoperative morbidity and mortality. 24, 25 Acute renal failure and new-onset hemodialysis indicate 2 very different degrees of insults on the kidneys. These complications were significantly more common in patients with prior PCI.
There were some important differences to note between the 2 groups. Prior PCI patients more frequently received clopidogrel both preoperatively and postoperatively. Although there were no differences in stroke between groups, the greater clopidogrel use may explain the higher bleeding and reexploration rates in the PCI group. Furthermore, internal mammary artery use, known to improve short-and long-term mortality, was less frequently used in prior PCI patients. Finally, the number of arterial and venous grafts was significantly lesser in the PCI group. Both of these important variables were covariates in the multivariate analysis. Despite these differences, prior PCI remained a risk factor for major complications.
Several plausible reasons may explain these worse outcomes in prior PCI patients after CABG. Because removal of the coronary stent is damaging to the coronary artery, prior PCI procedure could result in less target vessel to revascularize at the time of subsequent CABG. Second, branch vessels may have been sacrificed in vessels that have undergone previous stenting. This, in turn, can limit the run-off of the target vessel and may cause CABG patency to be diminished. Other potential causes for adverse outcomes in prior PCI with subsequent CABG could be disruption of physiologic endothelial function of the coronary artery owing to stent placement or a more aggressive disease status. Indeed, it is not uncommon to see progression of angiographically nondiseased vessels after stent placement in disease coronary arteries. Prior PCI may be a marker for sicker/more ill patients and owing to the earlier mentioned vascular restraints along with a higher tendency to bleed owing to clopidogrel use, could very well lead to poor outflow of the vessel, thus effectively decreasing the cardiac output and possibly leading to acute renal failure, new-onset dialysis, and prolonged ventilation, which are unrelated to revascularization directly. This study has several limitations. The retrospective nature of the study introduced the possibility of inherent observational and selection bias. Completely deidentified patient data did not allow us to scrutinize certain aspects, including single or multiple prior PCI events, type and number of stents used, time interval between CABG occurrence and successful PCI, type of CABG surgery, quality of target vessel, and long-term major adverse cardiac events outcomes. The low overall operative mortality after CABG procedures could explain the lack of difference in mortality between the no PCI and prior PCI groups. Finally, the potential influence of an unmeasured confounder may, in part, explain some of the estimated effects observed between groups. Nonetheless, the results of this study provide a very important insight to base future prospective studies.
In conclusion, in this study, we document that the incidence of prior PCI in patients undergoing CABG is increasing. Importantly, previous PCI was not associated with operative mortality. However, it is associated with a significantly higher incidence and risk of major complications, longer duration of stay, and higher readmission rates after CABG.
As such, history of PCI should be considered a risk factor in patients being evaluated for CABG.
Fig. 1.
Increase in incidence of prior PCI in CABG. 
